Lannett Company, Inc. (LCI)
-NYSE MKT 12.03 
0.12(0.99%) 4:00PM EDT|After Hours
:
12.03 0.00 (0.00%) 4:31PM EDT
| Prev Close: | 12.15 |
|---|
| Open: | 12.15 |
|---|
| Bid: | 10.94 x 100 |
|---|
| Ask: | 15.00 x 500 |
|---|
| 1y Target Est: | 13.69 |
|---|
| Beta: | 0.98 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 11.86 - 12.55 |
|---|
| 52wk Range: | 3.72 - 12.57 |
|---|
| Volume: | 82,574 |
|---|
| Avg Vol (3m): | 155,874 |
|---|
| Market Cap: | 345.06M |
|---|
| P/E (ttm): | 30.69 |
|---|
| EPS (ttm): | 0.39 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Favorable Verdict for MylanZacks(Wed 6:10PM EDT)
- LANNETT CO INC FinancialsEDGAR Online Financials(Fri, May 17)
- Here's Why Lannett's Latest Report Might Worry Youat Motley Fool(Thu, May 16)
- Socially Responsible Investing in Biotech and Pharmaceutical Companies: Expert Portfolio Manager Finny Kuruvilla Discusses His Construction Strategy with The Wall Street TranscriptWall Street Transcript(Thu, May 16)
- Isis Gets $3.5M Milestone PaymentZacks(Tue, May 14)
- Narrower-than-Expected Loss at SupernusZacks(Tue, May 14)
- Setback for Endo Health on Opana ERZacks(Mon, May 13)
- Did These Stocks Miss or Beat Analyst Expectations?at Wall St. Cheat Sheet(Sun, May 12)
- Pacira Reports Wider LossZacks(Fri, May 10)
- Lannett Hits Estimates in Solid Quarterat Motley Fool(Thu, May 9)
- Wider-than-Expected Loss at AvanirZacks(Thu, May 9)
- LANNETT CO INC Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online(Thu, May 9)
- Lannett Management Discusses Q3 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, May 8)
- Earnings Beat at Endo Health, Sales SlipZacks(Wed, May 8)
- Lannett Co Inc Earnings: Here’s Why Investors Like These Resultsat Wall St. Cheat Sheet(Wed, May 8)
Key Statistics
| Forward P/E (1 yr): | 30.07 |
|---|
| P/S (ttm): | 2.38 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Jun-13)
: | 0.43 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.08 |
|---|
| Mean Recommendation*: | 1.5 |
|---|
| PEG Ratio (5 yr expected): | 1.14 |
|---|
Business Summary
Lannett Company, Inc., together with its subsidiaries, develops, manufactures, packages, markets, and distributes generic versions of branded pharmaceutical products in the United States.
View More